Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies

Hodgkin lymphoma is a highly curable disease. Although most patients achieve complete response following frontline therapy, key unmet clinical needs remain including relapsed/refractory disease, treatment-related morbidity, impaired quality of life and poor outcome in patients older than 60 years. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohty, Razan, Dulery, Rémy, Bazarbachi, Abdul Hamid, Savani, Malvi, Hamed, Rama Al, Bazarbachi, Ali, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270913/
https://www.ncbi.nlm.nih.gov/pubmed/34244478
http://dx.doi.org/10.1038/s41408-021-00518-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270913/
https://www.ncbi.nlm.nih.gov/pubmed/34244478
http://dx.doi.org/10.1038/s41408-021-00518-z

Ejemplares similares